FR1088M - Médicament contre l'arthrite a base de 21-acétate de 6alpha,9alpha,16alpha-trifluoro-11beta,17alpha,21-trihydroxy-1,4-prégnadiene-3,20-dione. - Google Patents

Médicament contre l'arthrite a base de 21-acétate de 6alpha,9alpha,16alpha-trifluoro-11beta,17alpha,21-trihydroxy-1,4-prégnadiene-3,20-dione.

Info

Publication number
FR1088M
FR1088M FR858158A FR858158A FR1088M FR 1088 M FR1088 M FR 1088M FR 858158 A FR858158 A FR 858158A FR 858158 A FR858158 A FR 858158A FR 1088 M FR1088 M FR 1088M
Authority
FR
France
Prior art keywords
9alpha
6alpha
16alpha
11beta
pregnadiene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR858158A
Other languages
English (en)
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US51298A external-priority patent/US3239544A/en
Priority claimed from FR849322A external-priority patent/FR1456451A/fr
Application filed by Upjohn Co filed Critical Upjohn Co
Priority to FR858158A priority Critical patent/FR1088M/fr
Application granted granted Critical
Publication of FR1088M publication Critical patent/FR1088M/fr
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR858158A 1960-01-11 1961-04-08 Médicament contre l'arthrite a base de 21-acétate de 6alpha,9alpha,16alpha-trifluoro-11beta,17alpha,21-trihydroxy-1,4-prégnadiene-3,20-dione. Active FR1088M (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR858158A FR1088M (fr) 1960-01-11 1961-04-08 Médicament contre l'arthrite a base de 21-acétate de 6alpha,9alpha,16alpha-trifluoro-11beta,17alpha,21-trihydroxy-1,4-prégnadiene-3,20-dione.

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US144960A 1960-01-11 1960-01-11
US3676060A 1960-06-17 1960-06-17
US51298A US3239544A (en) 1960-08-23 1960-08-23 16-fluoro-11-hydroxy steroids of the pregnane series
FR849322A FR1456451A (fr) 1961-01-10 1961-01-10 Nouveaux 16alpha-fluoro et 16bêta-fluoro-stéroïdes et nouveaux stéroïdes intermédiaires ainsi que leurs procédés de fabrication
FR858158A FR1088M (fr) 1960-01-11 1961-04-08 Médicament contre l'arthrite a base de 21-acétate de 6alpha,9alpha,16alpha-trifluoro-11beta,17alpha,21-trihydroxy-1,4-prégnadiene-3,20-dione.

Publications (1)

Publication Number Publication Date
FR1088M true FR1088M (fr) 1962-01-29

Family

ID=27356927

Family Applications (1)

Application Number Title Priority Date Filing Date
FR858158A Active FR1088M (fr) 1960-01-11 1961-04-08 Médicament contre l'arthrite a base de 21-acétate de 6alpha,9alpha,16alpha-trifluoro-11beta,17alpha,21-trihydroxy-1,4-prégnadiene-3,20-dione.

Country Status (4)

Country Link
BE (1) BE598999A (de)
CH (2) CH407113A (de)
FR (1) FR1088M (de)
GB (2) GB946579A (de)

Also Published As

Publication number Publication date
GB946579A (en) 1964-01-15
CH407113A (de) 1966-02-15
GB946576A (en) 1964-01-15
BE598999A (fr) 1961-07-11
CH422774A (de) 1966-10-31

Similar Documents

Publication Publication Date Title
NZ182836A (en) 9 ,21-dihalo-6 -fluoro-11 ,17 -dihydroxy 16 -methyl-pregna-1,4-diene-3,20-diones
FR1088M (fr) Médicament contre l'arthrite a base de 21-acétate de 6alpha,9alpha,16alpha-trifluoro-11beta,17alpha,21-trihydroxy-1,4-prégnadiene-3,20-dione.
FR284M (fr) Médicament a base de 17-acétate de la 6 alpha-méthyl-9 alpha-fluoro-11 béta, 17 alpha-dihydroxy-1,4-prégnadiene-3,20-dione pour le traitement de l'aménorrhée.
CA605275A (en) 11-OXYGENATED-5.alpha.,17.alpha.,21-TRIHYDROXY-6-METHYL ALLOPREGNANE-3,20-DIONES, THE CORRESPONDING 3,20-DIALKYLENE KETALS, AND THEIR 21-ACYLATES
CA604331A (en) 2.alpha.-METHYL-9-HALO-11-OXYGENATED-4-PREGNENE-16,17,21-TRIOL-3,20-DIONE AND ITS 16,21-ESTERS
CA603202A (en) .DELTA.1,4-PREGNADIENE-16.alpha.,17.alpha.,21-TRIOL-3,11,20-TRIONE AND 16,21-ESTERS
CA536948A (en) 17.alpha.,21-DIHYDROXY-4-PREGNENE-3,11,20-TRIONE
CA603114A (en) .DELTA.4-PREGNENE-16.alpha.,17.alpha.,21-TRIOL-3,20-DIONES AND 16.alpha.,21-ESTERS
CA605628A (en) 11-oxygenated-6-fluoro-21-hydroxy-1,4-pregnadiene-3,20-diones
FR1326M (fr) 3- ou 17-semiacétals ou 3,17-disemiacétals de stéroides de la série de l'androstane.
CA594743A (en) 11.beta.,17.beta.-DIHYDROXY-17.alpha.-ALKYLANDROSTANE-3-ONES, THEIR 19-NOR DERIVATIVES, AND THE MONO- AND DI-ACYLATES THEREOF
CA635506A (en) 2-methyl .delta.1 4-pregnadienes-16,17,21-triol-3,20-dione oxygenated in the 11-position and its 16,21-esters
CA592278A (en) 6-FLUORO-11-OXYGENATED-17.alpha.-HYDROXY-1,4-PREGNADIENE-3,20-DIONES
CA704596A (en) 2,6.alpha.-DIMETHYL-11,17-DIOXYGENATED-9.alpha.-HYDROGEN-21-FLUORO AND 9.alpha.-21-DI-FLUORO-1,4-PREGNADIENE-3,20-DIONES
FR2650M (fr) 16,17-acétals et cétals de stéroides de la série des 16α, 17α-dihydroxy-19-nor-3-alkoxy-1,3,5(10)-pregnatrienes.
CA624112A (en) 6.alpha.-METHYL-17.alpha.,21-DIHYDROXY-4-PREGNENE-3,20-DIONES
CA615845A (en) 11-OXYGENATED-17.alpha.-HYDROXY-21-FLUORO-1,4-PREGNADIENE-3,20-DIONES
CA622321A (en) 11-OXYGENATED-6-METHYL-17.alpha.-HYDROXY-1,4-PREGNADIENE-3,20-DIONES
CA622323A (en) 11-OXYGENATED-6-METHYL-17.alpha.-HYDROXY-21-FLUORO-1,4-PREGNADIENE-3,20-DIONES
CA622325A (en) 11-OXYGENATED-6-METHYL-9.alpha.,21-DIFLUORO-17.alpha.-HYDROXY-1,4-PREGNADIENE-3,20-DIONES
CA622419A (en) 6-METHYL-17.alpha.-OXYGENATED -1,4-PREGNADIENE-3,20-DIONES
FR2814M (fr) Médicament a base de δ<4>-prégnene-14.15-époxy-17α.21-diol-3.20-dione et de ses 21-esters.
FR1430064A (fr) Nouvelles 7-méthyl-9alpha-halo-11-oxygéno-17alpha, 21-dihydroxy-1, 4-prégnadiène-3, 20-diones
FR2476M (fr) Nouveaux stéroides de la série de l'androstane.
CA740875A (en) 9-halo-4-pregnene-16,17,21-triol-3,11,20-trione and its 16,21-esters